Title: The Phantom Menace of Gene Patents?
Authors: GAISSER SibylleHOPKINS Michael M.LIDDELL KathleenZIKA EleniIBARRETA RUIZ Dolores
Citation: NATURE vol. 458 p. 407-408
Publisher: NATURE PUBLISHING GROUP
Publication Year: 2009
JRC Publication N°: JRC50984
ISSN: 0028-0836
URI: http://www.nature.com
http://publications.jrc.ec.europa.eu/repository/handle/JRC50984
DOI: 10.1038/458407a
Type: Articles in Journals
Abstract: Some European clinical genetic laboratories still refuse to recognise the legitimacy of genetic testing patents arguing they are difficult to invent around, excessively increase test prices, and hinder innovation. To examine the extent of such impacts we surveyed European labs and found that, in fact, they generally had little experience of dealing with patents and require more support to negotiate the changing patent landscape around them. We suggest they may also need more leeway to pass on any resulting increased costs due to patented tests to public and private health insurers. While w some European clinical genetic laboratories refuse to recognise the legitimacy of such patents arguing they are difficult to invent around, excessively increase test prices, and hinder innovation. To examine the extent of such impacts we surveyed European labs and found that, in fact, they generally had little experience of dealing with patents and require more support to negotiate the changing patent landscape around them. We suggest they may also need more leeway to pass on any resulting increased costs due to patented tests to public and private health insurers.
JRC Institute:Institute for Prospective Technological Studies

Files in This Item:
There are no files associated with this item.


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.